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Post-mastectomy pain syndrome (PMPS) is a recognised complication of breast surgery although little is known about the long-term
outcome of this chronic pain condition. In 1996, Smith et al identified a prevalence rate of PMPS of 43% among 408 women in the
Grampian Region, Northeast Scotland. The aim of this study was to assess long-term outcome at 7–12 years postoperatively in this
cohort of women, to describe the natural history of PMPS and impact of pain upon quality of life. Chronic pain and quality of life were
assessed using the McGill Pain Questionnaire (MPQ) and Short Form-36 (SF-36). Of 175 women reporting PMPS in 1996, 138 were
eligible for questionnaire follow-up in 2002. Mean time since surgery was 9 years (s.d. 1.8 years). A response rate of 82% (113 out of
138) was achieved; 59 out of 113 (52%) women reported continued PMPS and 54 out of 113 (48%) women reported their PMPS
had resolved since the previous survey in 1996. Quality of life scores were significantly lower in women with persistent PMPS
compared to those women whose pain had resolved. However, for women with persistent PMPS, SF-36 scores had improved over
time. Risk factors for persistent PMPS included younger age and heavier weight. This study found that, of women reporting PMPS in
1996, half of those surveyed in 2002 continued to experience PMPS at a mean of 9 years after surgery.
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Post-mastectomy pain syndrome (PMPS) is a chronic pain
condition, typically neuropathic in nature, which can occur
following surgery to the breast. Persistent pain after mastectomy
was first reported during the 1970s, characterised as a dull,
burning and aching sensation in the anterior chest, arm and axilla,
exacerbated by movement of the shoulder girdle (Wood, 1978).
More recently, chronic pain has been reported after other breast
procedures, including lumpectomy, breast reconstruction, aug-
mentation and reduction (Wallace et al, 1996; Carpenter et al,
1998). The exact cause of PMPS is unclear, but various aetiological
theories have been postulated, including dissection of the
intercostobrachial nerve, intraoperative damage to axillary nerve
pathways and pain caused by neuroma (Vecht et al, 1989; Wallace
et al, 1996; Jung et al, 2003).
There is no standard definition for PMPS, although the
International Association for the Study of Pain has defined
chronic pain as that persisting beyond the normal healing time
of 3 months (IASP, 1986). The frequency of PMPS ranges from 4 to
56%, depending on the definition used and method of assessment
(Vecht et al, 1989; Tasmuth et al, 1995; Wallace et al, 1996).
Although evidence regarding the epidemiology of PMPS is
growing, little is known about risk factors for the development
of PMPS, or the long-term outcome of this chronic pain condition
(Jung et al, 2003).
In 1996, an epidemiological study was conducted to determine
the prevalence of chronic pain in women undergoing mastectomy
for breast cancer in the Grampian Region, Northeast Scotland
(Smith et al, 1999). A cumulative prevalence of 43% (175 out of
408 women) was reported at three years (mean) postoperatively.
The aim of this follow-up study was to investigate the long-term
outcome in the 175 women who had reported PMPS.
Specific objectives were to assess the long-term prognosis,
risk factors and quality of life in this cohort of surviving women
who were between 7 and 12 years after surgery at the time of
second follow-up.
MATERIALS AND METHODS
Study design and sample size
A cohort study design was used to assess the outcome of women
who underwent a mastectomy procedure (OPCS-4 Operation
Codes B272–B279) in Grampian University Hospitals Trust
between 1990 and 1995. Six categories of mastectomy
were included: total, subcutaneous, excision of both pectoral
muscles, excision of pectoral minor, other and unspecified.
A total of 408 women were surveyed in 1996; of these, 175 women
reported PMPS and were eligible for follow-up in 2002. Of the 175
women reporting PMPS, 149 (85%) had total mastectomy. Ethical
approval for the follow-up study was granted from the Grampian
Research Ethics Committee of NHS Grampian and University of
Aberdeen.
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sTracing process and study procedures
The Community Health Index unique identifier was used by the
Grampian Health Board to check vital status, current address and
general practitioner (GP) for the 175 women. Patients now residing
outside of the Grampian Region were not traced. Letters were sent
to GPs for each patient, to inform them of the study and to avoid
inappropriate enquiry.
Definition and measurement of chronic pain
Chronic pain was defined as PMPS based on three criteria:
character, location and timing of pain. The same criteria for PMPS
were used at both time points to ensure comparability. Pain nature
was assessed for neuropathic characteristics, including numbness,
pins and needles, burning or stabbing. Pain location was recorded
as the same side of surgery, chest wall, axilla or ipsilateral arm.
Timing of pain was defined as persisting either continuously or
intermittently for longer than the normal healing time of 3 months
(IASP, 1986). Cumulative prevalence accounts for variability of
pain onset and duration, thus indicating the number of women
with persistent or intermittent PMPS between the two survey time
points. Point prevalence was used to denote women reporting
PMPS on the actual day of second survey.
Questionnaire design
The survey instrument was based on the baseline PMPS ques-
tionnaire with minor modifications to account for changes in timing
(Smith et al, 1999). Quality of life was assessed using the Short Form-
36 (SF-36) (Ware et al, 1993). Pain characteristics were quantified
using the McGill Pain Questionnaire (MPQ) and the University of
California and San Francisco (UCSF) Pain Service questionnaire
(Melzack, 1983; Fields, 1987). Patients were asked to complete upper
body pain charts using different graphical symbols for numbness,
pins and needles, burning, stabbing and ache (Boureau et al,1 9 9 0 ) .
Free-text sections were included for women to describe their
experience with pain, limitations of daily activities and coping
strategies. Questionnaires were sent with a covering letter and
stamped addressed envelope; one reminder was sent after 3 weeks.
Statistical analysis
Data were analysed using SPSS for Windows (version 11.0). P-
values of less than 0.05 were considered statistically significant.
The MPQ was analysed using three methods as described by
McDowell and Newell (1987): the Pain Rating Index using scale
weight values (PRI); the Pain Rating Index using scale weighted-
rank values (PRI-R); the number of words chosen (NWC) as per
analysis of the baseline data (Bruce et al, 2004). For the UCSF
questionnaire, numbers of women with symptoms were reported.
For ordered categorical variables, the w
2 test for trend was used.
Independent-samples t-tests were used for comparing pain and
pain-free groups. Paired t-tests were used to compare the mean
MPQ and SF-36 values over time. Multiple regression was used to
compare SF-36 domains across pain groups; analysis was adjusted
for age to account for known relationship between increasing age
and lower quality of life. Standard syntax was used to calculate SF-
36 scores where responses were summed and transformed to
generate dimension scores ranging from 0 (poor health) to 100
(excellent health).
RESULTS
Sample tracing and response rate
Of the 175 women with PMPS eligible for follow-up in 2002, 30
patients had died, four had transferred out of Grampian Region
and three GPs refused further contact. A questionnaire survey was
administered to 138 eligible women; 121 (88%) were returned, of
these eight were blank or incomplete. The results are based on 113
out of 138 responses with complete data (82%) (Figure 1).
Characteristics of responders
The mean time since breast surgery was 9.1 years (s.d. 1.8 years).
The mean age of women at follow-up was 62 years (s.d. 10.5 years).
Most women were currently married (64%) and a quarter of
responding women (25%) lived alone. Of the 113 women reporting
persistent PMPS, 96 (85%) had undergone a total mastectomy; 13
(12%) total mastectomy with excision of both pectoral muscles;
four (3%) had undergone subcutaneous mastectomy.
Prevalence of persistent PMPS
Of 113 women who reported PMPS in 1996, 59 (52%) women
reported having PMPS since that time, 43 (38%) reported their
pain had resolved and 11 (10%) had pain elsewhere unrelated to
surgery (e.g. arthritis, back pain). The cumulative prevalence of
PMPS at a mean of 9 years postoperatively was 52% (59 out of 113)
for the follow-up sample. A total of 42 of 113 women reported
having PMPS on the day of the 2002 survey, a point prevalence rate
of 37%. Of the 59 women reporting persistent PMPS, 45 reported
problems when using their arm and 24 still had arm swelling on
the side of breast surgery.
The previous survey in 1996 had estimated that 175 out of 408
(43%) of women had PMPS at a mean of 3 years after surgery.
Excluding 62 patients lost to follow-up (dead, not traced, refusals
and nonrespondents) from the 408 denominator and assuming
that the 233 women who were painfree in 1996 did not
subsequently develop PMPS, our second survey suggests that 59
out of 346 (17%) women will have PMPS at some point between a
mean of 3 and 9 years after surgery (range 7–12 years).
Risk factors for persistent PMPS
Women with persistent PMPS up to 2002 were younger than those
whose pain had resolved (mean age 49.5 vs 56.2 years; t-test;
Po0.001). The frequency of PMPS decreased with age from 91% in
women aged 30–49 years, to 55% in women aged 50–69 years, to
29% in women aged 70 years and over (w
2 test for trend; Po0.001).
Women with persistent PMPS were significantly heavier than
women whose pain had resolved by 2002 (Table 1). No significant
differences were found in body mass index between those with
persistent and resolved chronic pain, or in the mean time since
breast surgery between the two groups (Table 1).
Characteristics of persistent PMPS
The MPQ pain scores reported in 1996 and 2002 were compared; a
total of 47 out of 59 women reporting PMPS (80%) completed the
MPQ at both time points. A nonsignificant reduction in PRI and
PRI-R scores was noted over time, suggesting a decrease in pain
intensity (Table 2). The mean number of adjectives chosen to
describe PMPS was significantly lower in 2002 compared to 1996
(7.4 vs 5.9; P¼0.04, Table 2). Sensory-discriminative descriptors
were chosen more frequently than motivational-affective, cogni-
tive-evaluative or miscellaneous terms. The most frequently
selected MPQ terms were: stabbing (n¼20), shooting (n¼17),
aching (n¼17), gnawing (n¼14), nagging (n¼14), annoying
(n¼13), numb (n¼13), tiring (n¼13) and tight (n¼12). All of
the 17 women who reported ache also selected other pain
descriptors.
Analysis of the UCSF questionnaire was undertaken: 21 out of 59
(36%) of women reporting pain in 2002 described the intensity of
their pain as variable, 12 reported a decrease in intensity and four
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missing). Sleep was unaffected for most women (n¼30), but
others reported sleep was interrupted one to two nights per week
(n¼11) or for more than three nights per week (n¼10). Pain was
predominantly aggravated by straining (n¼42), lying down
(n¼11), cold weather (n¼8), clothes rubbing against the scar
(n¼8) and getting out of bed (n¼8). The pain was improved by
sitting (n¼9) and, for some women, lying down (n¼11).
Activities such as lifting, carrying and general housework caused
problems. Stretching movements were described as exacerbating
the pain, and exercise was difficult, although some women used
exercise and physiotherapy in their treatment regimes. Women
described problems in daily activities that are usually ‘taken for
granted’, like walking, driving and working.
Table 1 Characteristics of women who were surveyed in 2002, 7–12 years after breast surgery (mean 9 years)
Persistent PMPS since 1996 PMPS resolved between 1996 and 2002
No. of patients Mean (s.d.) No. of patients Mean (s.d.) P-value
Age (years) 59 49.5 (9.8) 54 56.2 (10.9) 0.001
Weight (kg) 46 70.5 (12.4) 42 63.9 (9.1) 0.004
Height (m) 56 1.63 (0.1) 50 1.61 (0.1) 0.17
Body Mass Index 44 26.7 (4.7) 38 24.9 (4.5) 0.09
Time since breast surgery (years) 59 8.9 (1.9) 54 9.1 (1.8) 0.66
Table 2 Mean (s.d.) McGill Pain Questionnaire (MPQ) scores for women with persistent PMPS
Survey-1 1996 Survey-2 2002
MPQ domain N¼47; mean (s.d.) N¼47; mean (s.d.) Mean paired difference
a (95% CI) P-value
Pain Rating Index (PRI) 18.34 (11.8) 15.76 (12.5) 2.58 ( 0.8, 5.9) 0.13
Pain Rating Index-Ranked (PRI-R) 16.17 (10.6) 14.68 (12.4) 1.49 ( 1.6, 4.6) 0.33
Number of words chosen (NWC) 7.34 (4.4) 5.96 (4.4) 1.38 (0.1, 2.7) 0.036
aDifference in mean pain scores compared between 1996 and 2002, t-test.
1996 Survey-1 
Follow-up (mean) 3 years postoperatively
2002 Survey-2 
Follow-up (mean) 9 years postoperatively 
Ineligible 
n=3 GP refusals 
n=408 women  
surveyed
n=233 painfree  n=175 PMPS
n=175 PMPS
n=138 eligible for  
follow-up survey 
n=30 died 
n=4 Transfers 
n=113 respondents  n=25 non-responders 
n=59 persistent  
PMPS 
  
42/59 pain on the day of  
survey
n=43 PMPS resolved  
between 1996 and 2002 
Figure 1 Flowchart of surveys and follow-up rates.
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Of the 59 women with persistent PMPS, most had tried one or
more treatments for pain relief (n¼53). The most commonly tried
method was conventional analgesia, either from a pharmacy or
prescribed by a GP (n¼35). Other women had tried other
nonpharmaceutical treatments or a combination of therapies, such
as physiotherapy, homeopathy, reflexology, reiki, acupuncture,
massage and counselling. Women described these therapies as
being helpful for ‘dealing with’ the pain; some also described
creating their own strategies for how best to live with chronic pain.
Free-text descriptions of alternative approaches included ‘mind
over matter’, ‘sunny holidays’ and ‘just getting away from it all’.
Quality of life
Women with persistent PMPS up to 2002 had statistically
significantly lower SF-36 scores across all health domains, except
for role-emotional functioning, than women whose pain had
resolved since assessment in 1996. These findings persisted when
these results were adjusted for age using multiple regression
(Table 3). For those women reporting persistent PMPS, self-
reported quality of life was compared between the two survey time
points, 1996 and 2002 (mean 3–9 years postoperatively). Mean
scores had improved in all but one domain, role-emotional
functioning, and there was a statistically significant improvement
in physical functioning (Table 4).
DISCUSSION
This study reports on the long-term prognosis and quality of life in
a cohort of women who reported chronic pain after breast surgery.
A cumulative prevalence of 43% (175 out of 408) was identified in
1996 at a mean of 3 years after mastectomy surgery; 59 of the 113
(52%) women who completed questionnaires at follow-up in 2002
reported having continuing PMPS. Using the denominator of 346
women (408 original sample minus 62 losses to follow-up), our
study suggests that 17% (59 out of 346) women will have PMPS up
to 12 years postoperatively (mean 9 years). We cannot exclude the
possibility that women who were painfree in 1996 may have since
developed PMPS, although this is unlikely. Cumulative prevalence
was used to allow for the variability of onset and remission of pain.
However, a high-point prevalence rate was found in women who
were followed up, with 42 of 113 (37%) women reporting PMPS on
the day of survey in 2002, which is considerable given they had
breast surgery on average 9 years previously.
There is current debate over the definition and diagnosis of
neuropathic pain, currently defined by IASP as ‘pain initiated or
caused by a primary lesion or dysfunction in the nervous system’
(Merskey and Bogduk, 1994; Max, 2002). This definition focuses on
aetiology, thus is not applicable when categorising pain status
based on self-reported symptoms using questionnaire methodol-
ogy. We used a rigorous definition for PMPS based on nature
(neuropathic descriptors), location and timing of pain, as per the
1996 survey (Smith et al, 1999). In a comprehensive review of
neuropathic pain after breast cancer surgery, Jung et al (2003)
proposed four distinct pain syndromes: phantom breast pain,
intercostobrachial neuralgia (ICN), neuroma pain and other nerve
injury pain. Intercostobrachial neuralgia pain is that typically
accompanied by sensory changes in the distribution of the
intercostobrachial nerve, whereas neuroma pain is found in the
region of the scar on the breast, chest or arm, provoked by
percussion. It would be unreliable to attempt to categorise the
women in our study to these syndromes without detailed
neurological assessment. Nevertheless, it is likely that women in
our sample have ICN, neuroma pain or a combination of both.
Verbal descriptors of pain symptoms, along with neurological
examination, are widely used to diagnose neuropathic pain.
Neuropathic pain, therefore, is a categorical description rather
than a single entity (Krause and Backonja, 2003). Pain descriptors
reported by women in our study were similar to those reported at 3
years postoperatively: stabbing, shooting, aching and nagging
(Bruce et al, 2004). Although our sample of women completing the
MPQ at both time points is small, terms used by women to
Table 3 Comparison of mean (s.d.) SF-36 scores in women with persistent and resolved PMPS (assessment 7–12 years after surgery)
SF-36 domain
Persistent PMPS
since 1996 (N¼59)
PMPS resolved between
1996 and 2002 (N¼54)
Mean difference
(95% CI)
a P-value
Physical functioning 60.4 (30.7) 74.6 (25.0)  14.2 ( 25.1,  3.3) 0.01
Role – physical 54.4 (44.1) 72.4 (40.6)  18.1 ( 34.5,  1.6) 0.03
Bodily pain 55.8 (26.5) 76.9 (21.6)  21.1 ( 30.3,  11.9) o0.001
General health perceptions 60.7 (23.7) 73.1 (18.4)  12.4 ( 20.7,  4.0) 0.004
Vitality 49.4 (24.4) 64.5 (19.2)  15.2 ( 23.3,  6.9) o0.001
Social functioning 73.3 (31.2) 86.6 (21.3)  13.3 ( 23,  3.4) 0.009
Role – emotional 69.0 (42.2) 81.3 (37.0)  12.3 ( 27.5, 2.6) 0.11
Mental health 71.4 (21.6) 80.5 (13.7)  9.1 ( 15.9,  2.3) 0.009
aMultiple regression adjusted for age.
Table 4 Comparison of mean (s.d.) SF-36 scores over time in women with persistent PMPS between 1996 and 2002
SF-36 domain
No. of
women
1996 Mean (s.d.)
score
2002 Mean (s.d.)
score
Difference of means
(95% CI)
a P-value
Physical functioning 57 59.7 (30.5) 67.1 (26.8)  7.4 ( 12.5, 2.2) 0.006
Role – physical functioning 54 54.2 (44.2) 56.5 (42.4)  2.3 ( 13.6, 8.9) 0.68
Bodily pain 58 55.8 (26.5) 61.9 (24.4)  6.2 ( 12.7, 0.4) 0.06
General health perceptions 56 61.6 (23.7) 66.5 (23.7)  4.94 ( 10.3, 0.4) 0.07
Vitality 59 49.4 (24.4) 51.4 (23.2)  2.09 ( 8.7, 4.5) 0.53
Social functioning 59 73.3 (31.2) 79.2 (23.7)  5.93 ( 13.2, 1.3) 0.11
Role – emotional 54 72.8 (39.9) 72.2 (40.3)  0.62 ( 11.8, 13.1) 0.92
Mental health 59 71.4 (21.7) 72.0 (17.3)  0.61 ( 6.5, 5.3) 0.84
aMultiple regression, adjusted for age.
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sdescribe their PMPS are similar to adjectives reported in other
studies (Stevens et al, 1995). Ache was selected within the MPQ by
30% of women with PMPS in the 2002 survey, although none of the
women described their pain as ‘ache’ alone. In 1990, Boureau and
colleagues used the French version of the MPQ to differentiate
neuropathic pain descriptors from non-neuropathic pain descrip-
tors. The descriptor ‘ache’ was classified as non-neuropathic; this
categorisation was adopted in the 1996 PMPS study, whereby
women reporting only ache (n¼39) were excluded from further
follow-up. Given the considerable variation in signs and symptoms
of neuropathic pain, some of these women may indeed have had
nerve-related injury after breast surgery.
Although pain descriptors are used to differentiate between
neuropathic and non-neuropathic pain, particularly in population-
based studies, few studies have explored the discriminative and
predictive ability of specific descriptors. Krause and Backonja
recently published a 12-item Neuropathic Pain Questionnaire
(NPQ), based on an original 32-item list that included ‘dull, aching
pain’. This list was administered to patients with neuropathic and
non-neuropathic pain; dull ache was dropped from the final 12-
item NPQ; the three-term short form version included ‘numbness,
tingling and increased pain due to touch’ (Backonja and Krause,
2003; Krause and Backonja, 2003). In contrast, Galer and Jensen
(1997) include ‘dull and aching pain’ within the Neuropathy Pain
Scale (NPS).
This is the first study to assess long-term prognosis of PMPS and
to explore change in health-related quality of life over time. The
SF-36 is a valid measure of change in population health and is also
responsive to quality of life changes in patients with chronic pain
conditions, for example, low back pain, widespread pain and post-
operative pain (Ware, 2000). In general, female sex and increasing
age are associated with poorer health-related quality of life, with
physical health scores tending to decline greater than mental
health (Lyons et al, 1994; Walters et al, 2001). UK population
‘norms’ for mean SF-36 scores have been published, based on
large-scale surveys in English populations (Jenkinson et al, 1993;
Bowling et al, 1999). These surveys found that women aged 60–64
years have higher than expected SF-36 scores, with scores being
higher than women in younger and older age categories (Bowling
et al, 1999; Walters et al, 2001). The mean age of women for the
Grampian cohort at second survey was 62 years. We found that,
overall, quality of life scores improved over time since surgery,
particularly for physical functioning. The mean SF-36 scores for
our female sample were lower for all health domains compared to
standard population scores, although statistical testing was not
undertaken.
Younger age and higher BMI were identified as risk factors for
persistent pain at a mean of 3 years postoperatively. Younger
women were more likely to have persistent pain at 9 years, and
although the association with heavier weight remained, BMI was
no longer a significant risk factor. The relationship with age is
unclear, as younger age has been identified as an independent risk
factor in some studies (Tasmuth et al, 1995) but not others
(Carpenter et al, 1998; Jung et al, 2003). It could be argued that
women with chronic pain may be less physically active, which
could contribute to heavier weight, yet mean physical functioning
scores improved over time in our sample. Younger age and obesity
have been reported as independent risk factors for chronic pain
after other surgeries, including inguinal herniorrhaphy and cardiac
surgery (Poobalan et al, 2001; Bruce et al, 2003). Given that the
majority of women in our sample underwent total mastectomy,
surgical procedure was not assessed as a risk factor. However, we
acknowledge that breast surgery has evolved since the 1990s, with
breast–conserving procedures, for example, lumpectomy with or
without axillary node dissection, now being conducted in up to
40% of breast cancer surgeries (Jung et al, 2003).
Although our sample size is small, our data suggest that the
intensity of PMPS decreases over time, but perhaps women have
also developed adaptation mechanisms or strategies to learn to
cope with persistent pain. The free-text data suggested that women
were very positive, suggesting they were highly motivated and
having survived breast cancer, happy to be alive. Despite having
problems with daily activities and having tried various modes of
therapies, women described ‘getting on with their lives’, trying to
live each day to the full within their own very specific limitations.
Our sample had tried conventional analgesia and other treatment
approaches, including relaxation, reflexology, reiki and massage,
mostly described as helpful in coping with persistent pain. Women
also expressed willingness to participate in the study; indeed, a
questionnaire response rate of 82% at 9 years postoperatively is
remarkable.
Our study is limited by the small sample size, the absence of
data on preoperative quality of life, pain intensity and analgesic
consumption in the acute postoperative period. Increased
pain intensity in the immediate postoperative period after breast
surgery is associated with the development of chronic pain
(Tasmuth et al, 1995). Identification of possible risk factors
is an important step in understanding the pathway and pro-
cesses for the development of chronic post-surgical pain.
Future intervention studies should be designed to target specific
risk groups and identify those most in need of preventive
strategies.
This study reports on the long-term outcome of 175 women
assessed at a mean of 3 and 9 years after breast cancer surgery.
There was a suggestion of a decrease in the intensity of pain over
time although neuropathic characteristics of PMPS remained
constant. For women with persistent PMPS up to 2002, there was
gradual improvement in quality of life from 3 years postopera-
tively, although health-related quality of life was poorer compared
to women whose PMPS had subsequently resolved. Younger age
and heavier weight were independent risk factors for PMPS at both
time points. Surgeons should be aware that younger and heavier
women may be at a higher risk of developing chronic pain
syndromes after breast cancer surgery. All women undergoing
breast cancer surgery should be fully informed of the possibility of
developing chronic neuropathic pain syndromes.
ACKNOWLEDGEMENTS
We would like to extend our thanks to all the women who took the
time to fill in the questionnaires. Our thanks also go to Mrs Susan
Robertson for administrative help and skills in the initial data
entry.
REFERENCES
Backonja MM, Krause SJ (2003) Neuropathic pain questionnaire-short
form. Clin J Pain 19: 315–316
Boureau F, Doubrere JF, Luu M (1990) Study of verbal description in
neuropathic pain. Pain 42: 145–152
Bowling A, Bond M, Jenkinson C, Lamping DL (1999) Short Form 36 (SF-
36) health survey questionnaire: which normative data should be use?
Comparisons between the norms provided by the Omnibus Survey in
Britain, the Health Survey for England and the Oxford Healthy Life
Survey. J Pub Health Med 21: 255–270
Bruce J, Drury N, Poobalan AS, Jeffrey RR, Smith WCS, Chambers WA
(2003) The prevalence of chronic chest and leg pain following cardiac
surgery: a historical cohort study. Pain 104: 265–273
Breast cancer survivors with post-mastectomy pain syndrome
L Macdonald et al
229
British Journal of Cancer (2005) 92(2), 225–230 & 2005 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
sBruce J, Poobalan AS, Smith WCS, Chambers WA (2004) Quantitative
assessment of chronic post-surgical pain using the McGill Pain
Questionnaire. Clin J Pain 20: 70–75
Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ,
Studts JL, McGrath PC, Sloan D, Kenady DE (1998) Postmastectomy/
postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51:
1285–1292
Fields HL (1987) Pain. New York: McGraw-Hill
Galer BS, Jensen MP (1997) Development and preliminary validation of a
pain measure specific to neuropathic pain: the neuropathic pain scale.
Neurology 48: 332–336
International Association for the Study of Pain (IASP) (1986) Classification
of chronic pain. Descriptions of chronic pain syndromes and definitions
of pain terms. The International Association for the Study of Pain,
Subcommittee on Taxonomy. Pain 3: S1–S226
Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF-36) health
survey questionnaire: normative data for adults of working age. Br Med J
306: 1440–1444
Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH (2003) Neuropathic
pain following breast cancer surgery: proposed classification and
research update. Pain 104: 1–13
Krause SJ, Backonja MM (2003) Development of a neuropathic pain
questionnaire. Clin J Pain 19: 306–314
Lyons RA, Perry HM, Littlepage BN (1994) Evidence for the validity of the
short form 36 questionnaire (SF-36) in an elderly population. Age Ageing
23: 182–184
Max MB (2002) Clarifying the definition of neuropathic pain. Pain 96:
406–407
McDowell I, Newell C (1987) Measuring Health: A Guide to Rating Scales
and Questionnaires. New York: Oxford University Press
Melzack R (1983) The McGill Pain Questionnaire. New York: Raven Press
Merskey H, Bogduk N (eds) (1994) Classification of Chronic Pain –
Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms
2nd edn. Seattle: IASP Press
Poobalan AS, Bruce J, King PM, Chambers WA, Krukowski ZH, Smith WCS
(2001) Chronic pain and quality of life following open inguinal hernia
repair. Br J Surg 88: 1122–1126
Smith WCS, Bourne D, Squair J, Phillips DO, Chambers WA (1999) A
retrospective cohort study of post mastectomy pain syndrome. Pain 83:
91–95
Stevens PE, Dibble SL, Miaskowski C (1995) Prevalence, characteristics, and
impact of postmastectomy pain syndrome: an investigation of women’s
experiences. Pain 61: 61–68
Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E (1995) Pain and
other symptoms after different treatment modalities of breast cancer.
Ann Oncol 6: 453–459
Vecht CJ, Van de Brand HJ, Wajer OJ (1989) Post-axillary dissection pain in
breast cancer due to a lesion of the intercostobrachial nerve. Pain 38:
171–176
Wallace MS, Wallace AM, Lee J, Dobke MK (1996) Pain after breast surgery:
a survey of 282 women. Pain 66: 195–205
Walters SJ, Munro JF, Brazier JE (2001) Using the SF-36 with older
adults: a cross-sectional community-based survey. Age Ageing 30:
337–343
Ware JE (2000) SF-36 Health survey update. Spine 25: 3130–3139
Ware JE, Snow KK, Kosinski AS, Gandek B (1993) SF-36: Health
Survey Manual and Interpretation Guide. Boston, MA: Nimrod
Press
Wood K (1978) Intercostobrachial nerve entrapment syndrome. South Med
J 71: 662–663
Breast cancer survivors with post-mastectomy pain syndrome
L Macdonald et al
230
British Journal of Cancer (2005) 92(2), 225–230 & 2005 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
s